載入中
NASDAQIndustrialsAgricultural - Commodities/Milling
最新資料
US$1.66
+US$0.165 · +11.04%
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.
最新資料
US$1.66
+US$0.165 · +11.04%
盤中時間採用ET。市場資料可能有所延遲。
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.
盤中時間採用ET。市場資料可能有所延遲。
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 3450.8萬 USD | 2518.8萬 USD | 1267.2萬 USD | 549.8萬 USD | 210.2萬 USD |
| 銷貨成本 | 1403.2萬 USD | 1124.6萬 USD | 703.9萬 USD | 427.9萬 USD | 143.2萬 USD |
| 毛利 | 2047.6萬 USD | 1394.2萬 USD | 563.3萬 USD | 121.9萬 USD | 67萬 USD |
| 研究與開發 | 531.2萬 USD | 479.7萬 USD | 336.9萬 USD | 230.8萬 USD | 412.9萬 USD |
| 銷售、一般及管理費用 | 1914.2萬 USD | 1466.9萬 USD | 1207.6萬 USD | 935.2萬 USD | 475.9萬 USD |
| 營業費用 | 2605.1萬 USD | 2093.1萬 USD | 1559.9萬 USD | 1183.1萬 USD | 916.1萬 USD |
| 利息收入 | 5.4萬 USD | — | — | — | — |
| 利息支出 | 272.3萬 USD | 193萬 USD | 196.2萬 USD | 139.9萬 USD | 80.5萬 USD |
| 折舊和攤銷 | 162.4萬 USD | 125.1萬 USD | 84萬 USD | 71.2萬 USD | 38.56萬 USD |
| 營業利益 | −557.5萬 USD | −698.9萬 USD | −996.6萬 USD | −1061.2萬 USD | −849.1萬 USD |
| 淨利 | −1113.5萬 USD | −1291.3萬 USD | −1256.4萬 USD | −1123.6萬 USD | −982.7萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
評級樣本有限，僅3項
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
